A complaint about a compounded sterile preparation is the start of a formal process, not an informal conversation closed out with an apology. USP 797 requires compounding facilities to log the complaint, investigate it, decide whether it triggers a recall, and document corrective and preventive action (CAPA) tied to the root cause. State board of pharmacy inspections built around the current chapter ask for all four, by name, in writing. On the day of an inspection, the complaint record, the investigation file, and the CAPA log are what the inspector checks first.
What Counts as a Complaint Under USP 797
USP 797 treats a complaint as any report that a compounded sterile preparation may not meet quality or purity expectations, reviewed in the same quality system as adverse events. Section 18.2 requires a readily retrievable record of each complaint, created and retained, not a verbal note in a staff log. The designated person who reviews the complaint decides next whether it indicates a potential quality problem with the preparation, which is when the investigation duty attaches under the same section. A complaint that turns out to describe an adverse event also triggers the facility's separate reporting duties under Section 18.3, covered in Adverse Event Reporting for Compounded Preparations.
Under USP 797, a complaint closes only when the investigation, and any corrective action it requires, are documented.
Investigating a Complaint and the Recall Decision
A complaint investigation can surface facts that point toward a recall: a quality defect in a batch already dispensed, a failed sterility or endotoxin result that returns after the preparation left the pharmacy, or a complaint that a preparation failed before its assigned beyond-use date. USP 797 ties the recall decision to the designated person's assessment of severity and the preparation's actual distribution, not to the format in which the complaint arrived. The recall process itself, including notification and reporting obligations, is covered in Recalling a Compounded Drug: Process and Exposure. The complaint record and the recall record for the same lot have to match, line for line.
Documenting Corrective and Preventive Action
CAPA under USP 797 has two separable parts, not a generic improvement plan logged after the fact. The correction addresses the specific preparation or the specific failure already in front of the facility. The prevention addresses why the same root cause would not recur. The chapter's own example is environmental monitoring: when microbial growth exceeds an action level, the facility investigates the cause, takes corrective action, and reviews the data collected afterward to confirm the corrective action actually worked. The same two-step logic applies to a complaint-driven CAPA. A documented root cause, a documented correction, and a documented effectiveness check are the three entries an inspector expects to find in the same file, not scattered across separate logs.
What an Inspector Reviews
State board of pharmacy inspections built around the current USP 797/800 checklist ask for five things by name: a written QA/QC program documenting how the facility adheres to its procedures, prevents and detects errors, and evaluates and corrects complaints and adverse events; a complete record of every reported complaint and adverse reaction; the investigation and corrective action tied to each one; the facility's recall procedure; and proof that the designated person reviewed the overall QA/QC program and the compounding SOPs within the last 12 months. A facility that can produce the complaint log but not the investigation behind it, or the investigation but not the documented recall decision, is missing a piece the checklist calls out by name. A compounder's 503A/503B status changes the answer: a 503B outsourcing facility layers FDA's cGMP requirements on top of the chapter, so the same complaint can open two separate files instead of one.
Why Early Legal Counsel Is Critical
It is critical that compounding pharmacists promptly retain experienced healthcare defense counsel upon receiving an inspection finding, a complaint that may require a recall, or any other government inquiry. Early legal intervention can protect the facility's rights, ensure appropriate responses to inspector requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with regulators on the facility's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the facility to unnecessary risk.
How Health Law Alliance Can Help
Health Law Alliance has represented 2,500+ clients nationwide. The firm's compounding pharmacy attorneys represent compounding pharmacists in the inspection, investigation, and enforcement matters that follow a complaint, a recall decision, or a CAPA finding. If your facility is facing an open complaint, a recall question, or an inspection citation tied to an incomplete CAPA file, contact our USP 797/800 compounding defense team for a free, confidential consultation.





